FIELD: medicine.
SUBSTANCE: invention concerns activating P450CYP3A4 isoenzyme in patients with chronic cardiac failure. That is ensured by administering ethylmethylhydroxypyridine malate in a single dose of 50-200 mg.
EFFECT: higher clinical effectiveness of chronic cardiac failure.
9 ex, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INCREASING OXYGEN TENSION IN BLOOD OF PATIENTS WITH CHRONIC HEART FAILURE | 2013 |
|
RU2526185C1 |
| METHODS FOR IMPROVING PHARMACOKINETICS | 2010 |
|
RU2591830C2 |
| METHOD FOR TREATING CHRONIC HEART FAILURE | 2005 |
|
RU2304964C2 |
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC BRAIN ISCHEMIA | 2021 |
|
RU2752065C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ISCHEMIC HEART DISEASE WITH CARDIAC FAILURE COMPLICATED WITH ANAEMIA | 2012 |
|
RU2485960C1 |
| METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION | 2010 |
|
RU2422136C1 |
| METHOD FOR DIAGNOSIS OF CORONARY ARTERY STENOSIS RESTENOSIS IN PATIENTS WITH CORONARY HEART DISEASE WITH CHRONIC HEART FAILURE | 2017 |
|
RU2649131C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WITHIN 12 MONTHS AFTER DECOMPENSATION OF CHRONIC HEART INSUFFICIENCY | 2020 |
|
RU2756391C1 |
| METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE WITH A REDUCED EJECTION FRACTION WITHIN 12 MONTHS AFTER IMPLANTATION OF A CARDIOVERTER DEFIBRILLATOR | 2021 |
|
RU2758120C1 |
